Dr. Gregory L. Ortega, MD

Dr. Ortega practices at Mid-Florida Hematology & Oncology Centers PA in Orange City, Florida.

Dr. Ortega's NPI, 1720037989, was assigned on May 8, 2006. Dr. Ortega graduated from Universidad Nacional Pedro Henriquez Urena in 1979. Dr. Ortega holds Florida license ME41521.

Dr. Ortega's primary practice is Mid-Florida Hematology & Oncology Centers PA, at 2776 Enterprise Rd, Orange City, FL 32763 in Volusia County. The practice phone is (386) 774-1223.

Dr. Ortega's primary practice is Mid-Florida Hematology & Oncology Centers PA in Orange City, Florida. Dr. Ortega is also affiliated with AdventHealth Fish Memorial. The medical group on file is Mid Florida Cancer Centers. Dmand AI also links Dr. Ortega to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ortega practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Ortega's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Ortega is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Ortega's licenses on file in 3 states: Florida, Tennessee and Indiana.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, deep vein thrombosis (DVT), lung cancer, lymphoma and multiple myeloma among the conditions Dr. Ortega treats.

CMS data shows 70,399 Medicare services from Dr. Ortega across 45 procedure codes in 2024, for 387 Medicare patients. Medicare paid $445,885 for them.

CMS counts 387 Medicare patients who saw Dr. Ortega in 2024. The largest group is 75 to 84, with 160 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 2.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ortega's median patient age at 72, with 61% women.

In 2024, Dr. Ortega wrote 1,547 Medicare Part D claims for 231 patients. 58% of them were for generic drugs. CMS names the drug for 1,182 of them, across 49 drugs with 11 or more claims each, at $3,286,821 in total drug cost. In 2023, CMS named 1,136 claims across 37 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Ortega for performance year 2024, reported as part of a group. Dr. Ortega accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Ortega in 2013. Dr. Ortega's most frequent co-authors are Lawrence B. Afrin, MD, David F. Claxton, MD and Solomon I. Hamburg, MD.

CMS Open Payments shows 37 general payments to Dr. Ortega from 17 drug and device companies from 2016 to 2024. Gifts make up the largest share, 89% of the total. Tosoh Bioscience, Inc. paid the most, $12,360. It also lists 1 research payment totaling $905 in 2017.

Dmand AI lists 2 awards for Dr. Ortega, most recently Checkbook Top Doc in 2012.

Dr. Ortega graduated from Universidad Nacional Pedro Henriquez Urena in 1979.

Dr. Ortega is in network with 19 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.